
Xsolla Capital


—Dr Thomas Ichim Founder and Director, Batu Biologics
of Choice. Over the last 10 years, Newstar Ventures has established a diverse and compelling portfolio of public and private companies across 3 different continents Originally focusing on early stage companies, the investment portfolio has now broadened and includes hedging strategies for small, medium, and large cap public companies as well as consideration of early stage private opportunities
2 images — click to enlarge
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about New Start Ventures.
Similar listings buyers compare against this one.

Xsolla Capital

Uniseed

Macquarie Capital

Gannet Capital

ETFS Capital

Legatum Ventures
Everything here links back to the same verified catalogue. Pick your next stop.